These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 17898331

  • 1. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.
    McClellan JM.
    Am J Psychiatry; 2007 Oct; 164(10):1462-4. PubMed ID: 17898331
    [No Abstract] [Full Text] [Related]

  • 2. Olanzapine versus placebo in the treatment of adolescents with bipolar mania.
    Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R, Wagner K, Findling R, Lin D, Robertson-Plouch C, Xu W, Dittmann RW, Biederman J.
    Am J Psychiatry; 2007 Oct; 164(10):1547-56. PubMed ID: 17898346
    [Abstract] [Full Text] [Related]

  • 3. Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis.
    Block JJ.
    Am J Psychiatry; 2006 Oct; 163(10):1838; author reply 1838. PubMed ID: 17012701
    [No Abstract] [Full Text] [Related]

  • 4. Olanzapine - relapse prevention following mania.
    Dando S, Tohen M.
    J Psychopharmacol; 2006 Mar; 20(2 Suppl):31-8. PubMed ID: 16551670
    [Abstract] [Full Text] [Related]

  • 5. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine.
    Tohen M, Calabrese JR, Sachs GS, Banov MD, Detke HC, Risser R, Baker RW, Chou JC, Bowden CL.
    Am J Psychiatry; 2006 Feb; 163(2):247-56. PubMed ID: 16449478
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial.
    Niufan G, Tohen M, Qiuqing A, Fude Y, Pope E, McElroy H, Ming L, Gaohua W, Xinbao Z, Huichun L, Liang S.
    J Affect Disord; 2008 Jan; 105(1-3):101-8. PubMed ID: 17531327
    [Abstract] [Full Text] [Related]

  • 7. Safety of olanzapine use in adolescents.
    Schulz C, Haight RJ.
    Expert Opin Drug Saf; 2013 Sep; 12(5):777-82. PubMed ID: 23876012
    [Abstract] [Full Text] [Related]

  • 8. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
    Citrome L, Holt RI, Walker DJ, Hoffmann VP.
    Clin Drug Investig; 2011 Sep; 31(7):455-82. PubMed ID: 21495734
    [Abstract] [Full Text] [Related]

  • 9. The effectiveness criterion: balancing efficacy against the risks of weight gain.
    Citrome L.
    J Clin Psychiatry; 2007 Sep; 68 Suppl 12():12-7. PubMed ID: 17956151
    [Abstract] [Full Text] [Related]

  • 10. Olanzapine for the treatment of bipolar disorder in children and adolescents.
    Strawn JR, Delbello MP.
    Expert Opin Pharmacother; 2008 Feb; 9(3):467-74. PubMed ID: 18220496
    [Abstract] [Full Text] [Related]

  • 11. [Olanzapine in the treatment of bipolar disorder].
    Krüger S.
    Psychiatr Prax; 2006 Mar; 33 Suppl 1():S18-26. PubMed ID: 16511727
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
    Vieweg WV, Sood AB, Pandurangi A, Silverman JJ.
    Acta Psychiatr Scand; 2005 Mar; 111(3):177-84. PubMed ID: 15701101
    [Abstract] [Full Text] [Related]

  • 15. Olanzapine and weight gain.
    Isaac MB, Isaac MT.
    Am J Psychiatry; 2005 Sep; 162(9):1764-5; author reply 1765. PubMed ID: 16135655
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?
    Deng C, Chen J, Hu C, Huang XF.
    J Clin Psychopharmacol; 2010 Aug; 30(4):480-1. PubMed ID: 20631576
    [No Abstract] [Full Text] [Related]

  • 18. Olanzapine may cause delirium in geriatric patients.
    Samuels S, Fang M.
    J Clin Psychiatry; 2004 Apr; 65(4):582-3. PubMed ID: 15119927
    [No Abstract] [Full Text] [Related]

  • 19. A review of the evidence for the use of antipsychotics in the maintenance treatment of bipolar disorders.
    Hellewell JS.
    J Psychopharmacol; 2006 Mar; 20(2 Suppl):39-45. PubMed ID: 16551671
    [Abstract] [Full Text] [Related]

  • 20. Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder.
    Gupta SK, Shwetank B.
    Indian J Pharmacol; 2014 Mar; 46(4):453-4. PubMed ID: 25097292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.